Arrhythmias & electrophysiology

Combining polygenic and clinical risk scores in atrial fibrillation risk prediction: Implications for population screening

Heart RhythmPublished Regression analysis

Authors' conclusion

Combining genetic and clinical risk using the HARMS2-AF and CHARGE-AF risk scores significantly improved AF risk prediction. Incorporating polygenic to clinical-risk scores may enhance population screening and promote targeted interventions to reduce the incidence of AF.

Study context

Population
United Kingdom Biobank participants with available whole genome sequencing dataparticipants with available whole genome sequencing data
Participants
285,734 participants
Comparison
AF-PRS combined with the HARMS2-AF and Cohorts for Heart and Aging Research in Genetic Epidemiology for AF (CHARGE-AF) risk scores and atrial fibrillation (AF) risk
Outcome
Incident AF
Follow-up
Median 12.9 years

Main finding

As reported in the abstract

AF incidence

6.6%

Median time to AF

8.5

5.0–11.2

Further findings

Incident AF risk, by AF-PRS tertile

HR (95% CI)P value
High AF-PRS tertile2.75 (2.62–2.89)P < 0.001
OutcomeValues
AF risk prediction, HARMS2-AF with AF-PRSHARMS2-AF AUC 0.828 · HARMS2-AF + AF-PRS AUC 0.839
AF risk prediction, CHARGE-AF with AF-PRSCHARGE-AF AUC 0.808 · CHARGE-AF + AF-PRS AUC 0.828
AF risk prediction, HARMS2-AF with AF-PRS — Overall net reclassification index
13.5% (12.8%-14.1%)
AF risk prediction, CHARGE-AF with AF-PRS — Overall net reclassification index
7.3% (6.7%-7.9%)
  • Incident AF risk, by AF-PRS tertile: after adjustment for clinical-risk factors; comparator not stated
  • AF risk prediction, HARMS2-AF with AF-PRS: DeLong P<.001
  • AF risk prediction, CHARGE-AF with AF-PRS: DeLong P<.001

Original publication

Combining polygenic and clinical risk scores in atrial fibrillation risk prediction: Implications for population screening. Heart Rhythm. Published 25 April 2025. doi:10.1016/j.hrthm.2025.04.032

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.